GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Well Lead Medical Co Ltd (SHSE:603309) » Definitions » EBIT

Well Lead Medical Co (SHSE:603309) EBIT : ¥267 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Well Lead Medical Co EBIT?

Well Lead Medical Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥71 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥267 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Well Lead Medical Co's annualized ROC % for the quarter that ended in Sep. 2024 was 12.16%. Well Lead Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 26.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Well Lead Medical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 7.92%.


Well Lead Medical Co EBIT Historical Data

The historical data trend for Well Lead Medical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Well Lead Medical Co EBIT Chart

Well Lead Medical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.30 200.55 146.81 211.47 244.58

Well Lead Medical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.23 60.39 64.94 71.35 70.59

Competitive Comparison of Well Lead Medical Co's EBIT

For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Well Lead Medical Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Well Lead Medical Co's EV-to-EBIT falls into.


;
;

Well Lead Medical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥267 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Well Lead Medical Co  (SHSE:603309) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Well Lead Medical Co's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=279.168 * ( 1 - 9.31% )/( (2084.128 + 2080.911)/ 2 )
=253.1774592/2082.5195
=12.16 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2774.715 - 264.274 - ( 599.617 - max(0, 589.929 - 1016.242+599.617))
=2084.128

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2737.309 - 229.006 - ( 427.392 - max(0, 483.416 - 920.782+427.392))
=2080.911

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Well Lead Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=282.352/( ( (887.821 + max(94.118, 0)) + (931.167 + max(192.236, 0)) )/ 2 )
=282.352/( ( 981.939 + 1123.403 )/ 2 )
=282.352/1052.671
=26.82 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(198.328 + 172.959 + 27.191) - (264.274 + 0 + 40.086)
=94.118

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(238.586 + 198.172 + 34.418) - (229.006 + 0 + 49.934)
=192.236

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Well Lead Medical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=267.255/3376.352
=7.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Well Lead Medical Co EBIT Related Terms

Thank you for viewing the detailed overview of Well Lead Medical Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Well Lead Medical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
Executives
Chen Bin senior management
Chen Yun Gui Directors, senior managers
Zhu Yi Min senior management
Han Guang Yuan Director
Xiang Bin Director
Fu Rong Supervisors
Zhao Tong Wei Supervisors

Well Lead Medical Co Headlines

No Headlines